Internal funding
Supporting Doctors in Their Academic Pursuit

The Department of Medicine is committed to enhancing academic careers by creating an environment & infrastructure that enables new recruits and existing faculty to become academically successful. As such, we commit substantial funds for yearly salary awards and run competitions for funding a variety of medical education and medical research projects.

CURRENT FUNDING OPPORTUNITIES

We are now accepting applications for our spring grant cycle. The submission deadline is Monday, May 3rd at 23:59.  Please take note of the additional opportunities below:

  1. Medical Education Grants are now being offered 2x/year (May and November) to align with clinical research opportunities. 
  2. We have added a new Virtual Care Innovation Grant to our program. In collaboration with the OHRI, DoM is offering $25K grants for clinical research in virtual care. These projects require the formation of a collaborative partnership between a DoM clinician and an Ottawa Methods Centre scientist (i.e. epidemiologist, implementation scientist, statistician, health economist, qualitative researcher etc.).

For full details, including application requirements, review criteria, conditions of awards and submission contact info for Medical Education Project Grants, Pilot/Feasibility Grants, Translational Research Grants and the new Virtual Care Innovations Grants please download this Internally Funded Research Awards Program document.

The DoM Academic Scholarship Program was developed to provide support to physicians in Department of Medicine specialties and subspecialties who are trying to establish an academic career in Medical Education, Research, or Quality of Clinical Services.

Completed applications should be submitted by March 1st, 2021 for academic scholarships starting in July 2021 or later. In cases when this is not possible, a brief letter of intent from the Division Head would be acceptable to defer the application deadline for an applicant although funding cannot be guaranteed for 2021 year. The letter of intent should contain the name of the applicant and the anticipated degree program as well as the expected date of commencement for the academic scholarship. Applicants can expect a response within 60 days.

 

Eligibility

Applicants:

  • Must be MDs with licensure in Ontario and eligible for membership in the RCPSC or its equivalent.
  • Cannot be MOH funded residents or the foreign equivalent.
  • Must be enrolled in a graduate studies program (degree offering program) for commencement of scholarship.
  • Cannot be current PTA (Part-time Academic) or FTA (Full-time Academic) members of a faculty of medicine
  • Must be sponsored by a Division within the Department of Medicine
  • Must have written commitment from the head of their sponsoring Division for a minimum of 50% time protection for academic activities.

Principles

 

  • These scholarships are for physicians who will have completed their specialty or subspecialty training by the start of their fellowship and are seeking academic careers in medicine.
  • The priority for funding will be for applicants currently training in Ottawa with the intent of being recruited as an FTA (Full-time Academic) in the DOM. Applications will also be considered from individuals who wish to train in Ottawa with the intention of seeking academic positions in Ottawa or elsewhere.

Conditions of Scholarship

 

  • The maximum amount of each scholarship will be $40,000 per year. Total amount of funding is dependent on the number of fellows being funded in any one year. The maximum term will be two years but the second year is contingent on submission of a report documenting satisfactory progress and a proposed work schedule demonstrating a minimum of ongoing 50% time protection for academic work.
  • Divisions are expected to provide salary support or billable clinical work to ensure that total annual income is at least equivalent to a current PARO PGY3 salary (currently $67,000 per annum)
  • Maximum income from all awards, billings, and Division contributions cannot exceed $150,000 per 12 month period. This includes work and moonlighting outside the Ottawa Hospital. Income from all sources must be reported to the DOM fellowship office.

Application

 

The application must be submitted to the DOM fellowship office as a single spaced document, in 12-point font (Arial or Times New Roman) and must adhere to page lengths below.  Page margins should be 2.5 cm minimum. 

  • Candidate CV

This section shall include a list of honours, awards, academic accomplishments, publications and abstract presentations, focusing on activities and achievements relevant to their scholarly field.

  • Letters of Support

The applicant must provide letters of support from the supervisor and from the Division Head.  One additional letter of reference may be submitted. The letter from the Division Head must guarantee 50% time protection during the fellowship and stipulate what salary support will be made available to the candidate. The letters of support should be structured to help the reviewers evaluate the characteristics and ability of the candidate, in terms of academic accomplishments, academic potential and interpersonal skills.

  • Academic (Career) Plan

Applicants must create and attach an academic plan detailing what their career intentions and goals are along with a discussion of strategies that will be used to achieve these goals. One page maximum (12-point font, single-spaced).

  • Research Project and research environment

Applicants should describe their research project, including the background, objectives, hypothesis, methodology, expected results and overall feasibility and significance. This should also include a brief description of the available resources and collaborators.

Applicants who are planning two year clinical scholarships should include a rough timeline of their activities over the two year period to justify the length of training. Three pages maximum (12 point font, single-spaced).

Selection Process

 

Applications will be reviewed by the DoM Director of Fellowships.  All completed applications will then be forwarded to the DOM Executive Committee for final review and approval.  The amount of funding in any given year varies depending on the departmental budget and the number of funded applications.  In the unlikely case that a scholarship request has been denied, the applicant’s division head may make an appeal directly to the DoM Executive Committee reconsideration.

Submit to DOM fellowship office

Dr. Grégoire  Le Gal

c/o Jean-Michel Bouchard

jeanbouchard@toh.ca

Ottawa Hospital, General Campus

Box 206, Ottawa, ON K1H 8L6

Accountability and Release of Funds

 

Funds will be released on a monthly basis or as required depending on the circumstances. Scholars will be required to provide confirmation of their enrolment in a graduate degree offering program in order for the funds to be released.

Scholars and sponsoring divisions are expected to notify the fellowship office of any interruptions in their training (e.g. maternity, paternity or sick leave etc.). In this event, funds may be held until training is resumed.

As with all DOM fellowships, scholars will need to receive quarterly evaluations by their supervisors, documenting satisfactory progress in their research and/or studies. The evaluation reports must be copied to the fellowship office.

In the event that satisfactory progress is not made against the goals of the fellowship and if after attempts at remediation have failed, the scholarship and funding will be terminated.

The scholar must submit a year-end report (2 pages max) to the fellowship office. The report should outline progress and accomplishments and be cosigned by the supervisor.

 In the case of applicants seeking a second year of funding, the report should be submitted at least 1 month prior to completion of the first year to assess eligibility for another year of funding and to establish the amount of funding available for the second year.

Year-end report should include:

  1. The number of courses completed with marks
  2. A description of any changes in research direction, and the rationale for such changes
  3. Status report on ongoing research projects
  4. Grant acquisition or submissions
  5. Publications or submissions
  6. Copy of thesis advisory committee report(s)
  7. Presentations
  8. Abstracts presented or submitted
  9. Include a description of clinical duties in the previous 12 months, and provide a copy of the clinical service schedule for the past year.

The expectation is that after their first year, scholars will have successfully completed all of the required coursework for their first year of a Masters of Epidemiology, Education or Quality of Clinical Services degree (or equivalent). Other degrees coursework may be permissible with prior approval of the fellowship office.  

It is also expected that after their second year, scholars will have completed and defended their Master’s thesis and completed or are nearing completion of their research project. Scholars who do not fulfill their objectives will be asked to provide an explanation and revised timeline for their project.

November 2020

Drs. Mark Campbell, Rosendo Rodriguez, Guy Trudel, Jen McDonald and Marc Monsour received $48,000 for their grant entitled “Peripheral nerve injections for the treatment of upper extremity complex regional pain syndrome: A feasibility study for a proposed randomized design”. This Developmental Research Grant was funded by the Department of Medicine ($40,000) and Division of Physical Medicine and Rehabilitation ($8,000).

Drs. James Downar, Shirley Bush, Peter Lawlor and Henrique Parsons received $47,800 for their grant entitled “Effects of Dexmedetomidine in patients with delirium in palliative care”. This Developmental Research Grant was funded by the Department of Medicine ($39,800) and Division of Palliative Care ($8,000).

Drs. Ed Spilg and Kylie McNeil received $35,571 for their grant entitled “Assessing the implementation and feasibility of the Stress Management and Resilience Training – Moral Resilience program (SMART-MR) with frontline clinical staff at The Ottawa Hospital: A non-randomized pilot study”. This Developmental Research Grant was funded by the Department of Medicine ($27,571) and Division of Geriatrics ($8,000).

Drs. Jill Fulcher and Marjorie Brand received $48,000 for their grant entitled “Identification of the cell surface marker profile of adult T-Acute Lymphoblastic Leukemia stem cells to guide the development of targetable immunotherapies”. This Translational grant was funded by the Department of Medicine($20,000), Ottawa Hospital Research Institute ($20,000) and Division of Hematology ($8,000).

May 2020

Dr. Robert Fahed received  $37,231 for his grant entitled “Impact of patient characteristics on assessment for endovascular stroke treatment (CASES)”

This Developmental Research Grant was funded by the Department of Medicine ($29,231) and Division of Neurology ($8,000).

Dr. Gregory Hundemer received $48,000 for his grant entitled “Characterizing Cardiovascular And Renal Disease In Subclinical Primary Aldosteronism”

This Developmental Research Grant was funded by the Department of Medicine ($40,000) and Division of Nephrology ($8,000).

November 2019

Dr. Edward Clark – Division of Nephrology received a Developmental Grant in the amount of $48,000.

Title – “Exploring the Relationship Between Mitochondrial Health and Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients”. Funding: $40,000 Department of Medicine, $8,000 Division of Nephrology.

Drs. Michel Shamy, Philip Berardi and William Stanford – Division of Neurology received a Translational Research Grant in the amount of $48,000. Title – “Integration of Molecular Genetic and Epigenetic Profiles to Predict Refractory Acute Myeloid Leukemia”. Funding: $20,000 Department of Medicine, $20,000 Ottawa Hospital Research Institute, $8,000 Division of Neurology.

May 2019

Dr. Sibel Aydin – Division of Rheumatology received a Developmental Research Grant in the amount of $46,750. Title - “A feasibility study on the prediction of response to treatment using musculoskeletal ultrasound in rheumatoid arthritis”. Funding: $38,750 Department of Medicine, $8,000 Division of Rheumatology.

Dr. Michel Shamy – Division of Neurology received a Developmental Research Grant in the amount of $46,248. Title - “Is a women-only trial in carotid stenosis ethically permissible?” Funding: $38,428 Department of Medicine, $8,000 Division of Neurology.

Drs. Xiaohui Zha and Alexander Sorisky – Division of Endocrinology and Metabolism received a Translational Research Grant in the amount of $48,000. Title “Researchers investigate how cholesterol regulates inflammation in white blood cells”. Funding: $20,000 Department of Medicine, $20,000 Ottawa Hospital Research Institute, $8,000 Division of Endocrinology and Metabolism.

November 2018

Dr. Kwadwo Kyeremanteng – Division of Palliative Care received a Developmental Research Grant in the amount of $21,206. Title – “Resource Optimization Network: A multi-disciplinary team to improve quality of care and reduce costs in the Intensive Care Unit”.

Drs. Marcel Ruzicka and Dylan Burger – Division of Nephrology received a Translational Research Grant in the amount of $48,000. Title -“Sex Differences in Platelet Microparticles on Dialysis”. Funding: $20,000 Department of Medicine, $20,000 Ottawa Hospital Research Institute, $8,000 Division of Nephrology.

May 2018

Dr. Juthaporn Cowan – Division of Infectious Diseases received a Developmental Research Grant in the amount of $40,000. Title – “Effect of chemotherapy on pneumococcal vaccine efficacy in patients with chronic lymphocytic leukemia”.

Drs Mark Freedman and Simon Thebault – Division of Neurology received a Developmental Research Grant in the amount of $23, 475. Title – “Can Serum Neurofilament Light Chain Predict Disease Severity in Multiple Sclerosis? A Pilot Study“.

Drs Angela Crawley, Curtis Cooper and Cynthia Tsien – Division of Infectious Diseases and Gastroenterology received a Translational Research Grant in the amount of $40,000. Title “Lasting immune dysfunction in HCV-associated end -stage liver disease”. Funding: $20,000 Department of Medicine, $20,000 Ottawa Hospital Research Institute, $8,000 Division of Infectious Diseases.

November 2017

Dr. Michel Shamy – Division of Neurology received a Developmental Research Grant in the amount of $16,618. Title “Fractality and Measures of Chaos in Transcranial Doppler: A Pilot Study of Cerebral Autoregulation in Subarachnoid Hemorrhage”

Drs. Mark Campbell and Jeffrey Dilworth – Divisions of Physical Medicine and Rehabilitation and Nephrology received a Translational Research Grant in the amount of $48,000. Title – “Determining the optimal bone-derived stem cell source niche for cartilage regeneration in the treatment of osteoarthritis.” Funding: $20,000 Department of Medicine, $20,000 Ottawa Hospital Research Institute, $8,000 Division of Neurology.

May 2017

Dr. Jennifer Beecker – Division of Dermatology received a Developmental Research Grant in the amount of $39,718. Title -“Systemic treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: A pilot study in advance of a Phase III clinical trial”.

Dr. Edward Clark – Division of Nephrology received a Developmental Research Grant in the amount of $39,988. Title – “Saline versus Albumin Fluid for Extracorporeal Removal with Slow Low Efficiency Dialysis”.

Dr. Tetyana Kendzerska – Division of Respirology received a Developmental Research Grant in the amount of $40,000. Title – “Validation of provincial health administrative data algorithms to identify patients with obstructive sleep apnea (OSA): Feasibility project”.

Drs. Rashmi Kothary and Michael Schlossmacher- Division of Neurology received a Translational Research Grant in the amount of $48,000. Title – “Filling a knowledge gap in multiple system atrophy, a lethal disease of oligodendrocytes”. ”. Funding: $20,000 Department of Medicine, $20,000 Ottawa Hospital Research Institute, $8,000 Division of Neurology.

November 2016

Dr. Jeff McCurdy- Division of Gastroenterology received a Developmental Research Grant in the amount of $35,000. Title – “The Risk of Venous Thromboembolism in Post-discharge Patients with Inflammatory Bowel Disease”.

Dr. Mitchell Sabloff - Division of Hematology received a Developmental Research Grant in the amount of $35,000. Title – “Dose-extended-Total Body Irradiation and Plerixafor followed by an Allogeneic Stem Cell Transplantation for the Treatment of Refractory Acute Leukemia”.

May 2016

Dr. Sanjay Murthy – Division of Gastroenterology received a Developmental Research Grant in the amount of $35,000. Title – “The Impact of a Physician Incentive Program on Continuity of Care and Health Outcomes in Inflammatory Bowel Disease and Cirrhotic Patients”.

Dr. Jodi Warman – Division of Neurology received a Developmental Research Grant in the amount of $35,000. Title-“LGMDx-Seq: An Transformative Diagnostic Exome/RNA Sequencing Pipeline for Patients with Limb Girdle Muscular Dystrophies”.

Dr. Lisa Duffett – Division of Hematology received a Developmental Research Grant in the amount of $35,000. Title-“Optimizing the Diagnosis of Heparin Induced Thrombocytopenia Using Quantified Anti-Platelet Factor 4 Immunological Testing: A Prospective Cohort Study”.

November 2015

Dr. Dar Dowlatshahi – Division of Neurology received a Developmental Research Grant in the amount of $35,000. Title – “Prospective evaluation of intraluminal internal carotid artery free-floating thrombus”.

Dr. Sunita Mulpuru – Division of Respirology, Dr. Kathryn Suh – Division of Infectious Diseases and Dr. Alan Forster – Division of General Medicine received a Developmental Research Grant in the amount of $33,004. Title – “Investigating Respiratory Infection Control Practice in Canadian Hospitals: A National Survey”.

Dr. Sanjay Murthy – Division of Gastroenterology received a Developmental Research Grant in the amount of $35,000. Title – “Development of Diagnostic Algorithms To Predict Disease Phenotype And Validation Of Service Codes In Adult-Onset Ulcerative Colitis Patients Using Ontario Health Administrative Data: A Pilot Study”.

May 2014

Dr. Kevin Burns – Division of Nephrology received a Developmental Research Grant in the amount of $18,281. Title – “Arterial stiffness in healthy subjects and patients with End‐Stage‐Renal Disease: A Feasibility Study”.

Dr. Bill Cameron – Division of Infectious Diseases, Dr. Greg Knoll – Division of Nephrology and Dr. Jason Tay - Division of Hematology received a Developmental Research Grant in the amount of $35,000.  Title – “Immunoglobulin therapy for secondary hypogammaglobulinemia: hematopoietic stem cell and renal transplantation”.

Dr. Tiago Mestre and Dr. David Grimes- Division of Neurology, Drs. Santanu Chakraborty and Gerd Melkus – Department of Medical Imaging received a Developmental Research Grant in the amount of $33,730.  Title – “Use of high resolution isotropic/three dimensional magnetic resonance imaging as a biomarker for the early distinction of Parkinson’s Disease from Atypical Parkinsonian Disorders”.

Dr. Shane English – Division of Critical Care received a Developmental Research Grant in the amount of $15,993. Title – “Aneurysmal subarachnoid hemorrhage- red blood cell transfusion associated mortality (SAHaRA): A Canadian Multicentre retrospective cohort study”.

Dr. Hussein Abujrad and Dr. Teik Chye Ooi – Division of Endocrinology received a Developmental Research Grant in the amount of $26,304.  Title – “PCSK9 and Pro-inflammatory Cytokines in Patients with Chronic Kidney Disease on Hemodialysis

Dr. Daniel Kobewka – Division of General Internal Medicine received a research fellowship for two years in the amount of $40,000.

November 2013

Dr.  Mitchell Sabloff – Division of Hematology received a Developmental Research Grant in the amount of $24, 777.  Title – “Extended dose – Total Body Irradiation Followed by an Allogeneic Stem Cell Transplantation for the Treatment of Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome”.

Dr. Rakesh Patel – Division of Critical Care received a Developmental Research Grant in the amount of $12,122.  Title – “Antimicrobial Pharmacokinetics in Critically Ill Adults during Sustained Low Efficiency Dialysis (SLED)”.

May 2013

Dr. Anne McCarthy – Division of Infectious Diseases received a Translational Research Grant in the amount of $11,379.  Title “Determining the optimal malaria chemoprophylaxis for travellers: Decision Analysis modeling to inform Public Health Policy”.

Dr. Esteban Gandara – Division of Hematology received a Developmental Grant in the amount of $32,302. Title – “Rivaroxaban for the Prevention of Restenosis after Infrainguinal Percutaneous Transluminal Angioplasty for Critical Limb Ischemia-The RIFLE study”.

 Dr. Rakesh Patel – Division of Critical Care received a Developmental Grant in the amount of $7,761.  Title – “Determining the Safety of Enoxaparin Prophylaxis in Critically Ill Adults with Severe Renal Insufficiency”.

Dr. Swapnil Hiremath – Division of Nephrology, Dr. Greg Knoll – Division of Nephrology and Dr. Dean Fergusson – Division of Clinical Epidemiology received a Research Priority Grant in the amount of $99,775.  Title “The Prevention of Acute Kidney Injury following Contrast-Enhanced Computed Tomography: A Pilot Trial of Oral Fluid versus Intravenous Saline”.

Dr. Vicente Corrales-Medina – Division of Infectious Diseases received a Research Priority Grant in the amount of $96,758. Title – “Vascular inflammation as measured by 18FDG-PET/CT scan during acute pneumonia: A feasibility study”.

Dr. Sunita Mulpuru – Division of Respirology received a research fellowship in the amount of $40,000 for one year.

Dr. Lana Castellucci – Division of Hematology received a research fellowship in the amount of 40,000 for one year.

Dr. Amber Molnar – Division of Nephrology received a research fellowship in the amount of 40,000 for two years.

November 2012

Dr. Jonathan Angel – Division of Infectious Diseases and Dr. John Bell – Division of Oncology received a Research Priority Grant in the amount of $99,200. Title “The study of recombinant Maraba virus as a potential approach to eliminate cells that constitute the HIV reservoir”

Dr. Doug McKim – Division of Respirology, Dr. Mark Freedman – Division of Neurology and Dr. Nadim Srour – Division of Respirology received a Research Priority Grant in the amount $ 30,870. Title “Lung volume recruitment for lung function and cough impairment in multiple sclerosis”

Dr. David Allan – Division of Hematology and Dr. Richmond Sy – Division of Gastroenterology received a Research Priority Grant in the amount of $100,000. Title: “Augmenting Immune Modulatory Properties of Mesenchymal stromal cells in Patients with Crohn’s Disease”

Dr. Curtis Cooper – Division of Infectious Diseases received a Translational Research Award in the amount of $25,000. Title: “Regulation of hepatic VLDL production: A novel strategy to treat HCV infection”

Dr. Dar Dowlatshahi – Division of Neurology received a Developmental Research Award in the amount of $25,000. Title: “Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study”

Dr. Dawn Sheppard – Division of Hematology received a Developmental Research Award in the amount of $15,159. Title: “Life-Threatening Toxicity Following Fludarabine-‐Based Therapy for Chronic Lymphocytic Leukemia: Clinical and Genomic Predictors”

Dr. Amber Molnar – Division of Nephrology received a research fellowship in the amount of $40,000 for two years.

May 2012

Dr. Naomi Spitale (Division of Respirology) received a 2 year research fellowship in the area of cardiovascular consequences of obstructive sleep apnea.

Dr. Dylan Blacquiere (Division of Neurology) received a 1 year research fellowship in the area of acute stroke management and stroke prevention.

Dr. Avi Chatterjee (Division of Gastroenterology) received a Developmental Team Grant to establish the Ottawa Pancreatic Cancer Research Group (OPCRG).

Dr. Marc Roger (Division of Hematology) Developmental Research Grant entitled PEAS Correlation Study (Pulmonary Embolism Ambulatory Oxygen Saturation Correlation Study)

November 2011

Dr. Jonathan Angel (Division of Infectious Diseases) received a Mid-Career Research Salary Award.

Drs. Carl Van Walraven and Raphael Saginur (Divisions of General Internal Medicine, and Infectious Diseases, respectively) received a Clinical Priority Research Award for their grant entitled “The Ottawa Hospital Outpatient Bacteremia (TOHOB) Study: The Epidemiology and Outcomes of Outpatient Bacteremias”.

Drs. Peter Lawlor and Shirley Bush (Division of Palliative Care) were awarded a Developmental Grant for their study entitled “The preventative role of exogenous melatonin administration in patients with advanced cancer who are at high risk of delirium: a feasibility study prior to a larger randomized controlled trial”.

Dr. Curtis Cooper (Division of Infectious Diseases) was awarded a Developmental Grant for his study, in collaboration with the Division of Endocrinology and Metabolism entitled “Evaluation of the Influence of Hepatitis C Protease Inhibitor-Containing Antiviral Therapy on Insulin Resistance and Lipid Profile”.

Dr. Todd Fairhead (Division of Nephrology) was awarded a Developmental Grant for his study entitled “Immunity in patients receiving extensive haemodialysis versus conventional in-home haemodialysis”.

May 2011

Dr. Nataliya Milman (Division of Rheumatology) was awarded a Research Fellowship.

Dr. Yoko Schreiber (Division of Infectious Diseases) was awarded a Research Fellowship.

Dr. Marion Doyle (Division of Endocrinology and Metabolism) was awarded a Research Fellowship.

Dr. Esteban Gandara (Division of Hematology) was awarded a Research Fellowship.

Dr. Dariush Dowlatshahi (Division of Neurology) was awarded a Pilot Feasibility Grant for his study entitled “Predicting early intracerebral hemorrhage expansion using the dynamic CT-angiography spot sign”.

November 2010

Dr. Paul MacPherson (Division of Infectious Diseases) was awarded a Mid-Career Award.

Dr. Alan Forster (Division of General Medicine) was awarded a Mid-Career Award.

Dr. Kirsten Hogg (Division of Hematology) was awarded a Research Fellowship.

Dr. Vicente Corrales-Medina (Division of Infectious Diseases) and Dr. George Wells were awarded a Clinical Research Priority Grant for their study “The Impact and Risk of Cardiac Complications in Patients with Community Acquired Pneumonia”.

Drs. Greg Knoll and Marc Rodger (Divisions of Nephrology and Hematology respectively) were awarded a Clinical Research Priority Grant for their study “The Implementation of a Computerized Decision Support System for Oral Anticoagulant Dosing in Hemodialysis Patients: A Study of Effectiveness and Safety in High-Risk Population”.

Dr. Alan Tinmouth (Division of Hematology) was awarded a Pilot Feasibility Grant for his study entitled “Safety and Efficacy of a Therapeutic Platelet Transfusion Strategy in Patients Receiving Outpatient-Based Care for Myelodysplastic Syndrome/Acute Myeloid Leukemia”.

May 2010

Dr. Carl van Walraven (Division of General Medicine) was awarded a Mid-Career Award.

Drs. Jonathan Angel and Edward O’Brien (Divisions of Infectious Diseases and Cardiology respectively) were awarded a Clinical Priority Grant for their study entitled “Circulating Endothelial Progenitor Cells in HIV-infected Men as a Marker of Cardiovascular Risk”.

Drs. David Allan and Kevin Burns (Divisions of Hematology and Nephrology respectively) were awarded a Clinical Priority Grant for their study entitled “Induction of angiogenic repair capacity in vascular progenitor cells”.

Dr. Smita Pakhale (Division of Respirology) was awarded a Pilot Feasibility Grant for her study entitled “Examining treatment adherence in adults living with CF”.

Dr. Grant Stotts (Division of Neurology) was awarded a Development Grant for the Establishment of the Ottawa Stroke Research Group (OSRG).

November 2009

Dr. Marc Rodger (Division of Hematology) was awarded a Research Chair Award.

Dr. Mark Freedman (Division of Neurology) was awarded a Mid-Career Award.

Dr. Miguel Bussiere (Division of Neurology) was awarded a Pilot Feasibility Grant for his study entitled “Effect of Weight Reduction on the Outcome of Patients with Idiopathic Intracranial Hypertension”.

Dr. Shawn Aaron (Division of Respirology) was awarded a Translational Research Grant for his study entitled “Investigating the Relation of Symptoms to Treatments and the Time Course of Chronic Obstructive Pulmonary Disease Using Threshold Regression.”

Department of Medicine members may also be eligible for funding support offered by the University of Ottawa. 

Note: This is a legacy site page that will be replaced in the coming months.